New psychedelic-like drugs: All treatment, no 'trip'?
California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.
Source: mercurynews.com
📰 Genentech News
Page 67 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
Relapsed DLBCL: Complete Interim Response, SCT Beats CAR T
'In patients with relapsed DLBCL in a complete remission, treatment with auto-HCT is associated with a lower rate of relapse/progression, and a longer progression-free survival [versus CAR T therapy].'
Source: medscape.com
Aiolos Bio Strengthens and Expands Leadership Team with Key Appointments
René van der Merwe, MBChB, appointed as Chief Medical Officer Tapan Maniar, Ph.D., joins as Chief Business Officer Company on track to initiate a Phase 2…
Aiolos Bio Khurem Farooq Clinical Program Global Clinical Development Mckinsey Company Head Of Clinical Development At Galvani Bioelectronics
Source: financialpost.com
New psychedelic-like drugs: All treatment, no 'trip'?
California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.
Source: eastbaytimes.com
Oral DEC-C Treatment Is Feasible and Comparable With IV/SC HMA Outcomes in MDS
Oral decitabine/cedazuridine and parenteral hypomethylating agents were associated with similar levels of comorbidities and disease burden in patients with myelodysplastic syndrome.
United States New Haven Samer Zeidan Daiichi Sankyo States Cerner Enviza Boehringer Ingelheim Incyte
Source: onclive.com
Dr Boreham's Crucible: Imugene - FNArena.com
Tim Boreham highlights the prospects for cancer treatment biotech Imugene
Source: fnarena.com
Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard of Care Regimen for Previously Untreated CLL
This is the first trial to show that a MRD-guided approach with treatment beyond MRD negativity has a significant advantage over chemotherapy, both in terms of PFS and OS.
United Kingdom United States American Society Of Hematology University Of Leeds International Workshop On Chronic Lymphocytic Leukemia Peter Hillmen
Source: pharmacytimes.com
Community Oncology Pharmacists Should Learn How to Manage Adverse Events Related to New Therapies for Acute Myeloid Leukemia
The pharmacist can help patients to manage symptoms throughout the entire treatment journey.
San Diego United States Fort Myers Natasha Khrystolubova American Society Of Hematology Pharmacy Clinical Services
Source: pharmacytimes.com
HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors
WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ -- HanAll Biopharma's partner NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nurr1-related human disorders, is pleased to announce the appointment of Dr. Almira Chabi, MD, EGMP to its Board of Directors, effective November 24, 2023. Dr. Chabi...
United States Deog Joong Kim Almira Chabi Prnewswire Hanall Biopharma Wharton Business School Executive Management Program Michaelj Fox Foundation
Source: asiaone.com
New Data Reinforce the Benefit of Early Preventative Treatment With Genentech's Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A | National Business
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Dec 9, 2023--
Source: joplinglobe.com